Cancer Imaging

Cancer Imaging is an open access peer-reviewed journal published by BioMed Central, part of Springer Nature, as the official journal of the International Cancer Imaging Society, founded in 2000 and devoted to the interdisciplinary field of cancer imaging, with a 2025 Journal Impact Factor of 4.8《癌症成像》是（Springer Nature）旗下（BioMed Central）出版的开放获取同行评审期刊，为国际癌症成像学会（ICIS）官方期刊，2000 年创刊，专注癌症成像这一交叉领域，2025 年影响因子为 4.8。

Scope

• The journal encompasses the interdisciplinary and innovative field of cancer imaging and publishes original research, reviews, correspondence and editorials written by international experts期刊涵盖癌症成像这一交叉与创新领域，发表由国际专家撰写的原创研究、综述、通信与社论。
• Imaging modalities in scope include CT, MR, PET, ultrasound, radionuclide imaging and multimodal imaging in all kinds of malignant tumours收稿范围涵盖各类恶性肿瘤的（CT）、（MR）、（PET）、超声、放射性核素成像与多模态成像。
• New developments, techniques and innovations in oncological imaging are a particular focus肿瘤成像的新发展、新技术与新应用是特别焦点。
• Section areas covered by the board include breast imaging, chest imaging, ear, nose and throat, gastrointestinal, and hepatobiliary and pancreatic imaging编委会覆盖的学部包括乳腺成像、胸部成像、耳鼻喉、胃肠与肝胆胰成像。
• Further section areas are interventional radiology, lymphoma, measurement of tumour response, molecular functional imaging, musculoskeletal imaging, neuro-oncology, nuclear medicine, paediatric imaging and imaging biomarkers其他学部涵盖介入放射、淋巴瘤、肿瘤疗效评估、分子功能成像、肌肉骨骼成像、神经肿瘤学、核医学、儿科成像与影像生物标志物。
• Complications of cancer treatment as seen on imaging form another recognised section癌症治疗并发症的影像表现是另一个受认可的学部。
• All articles are published open access under Creative Commons licences, giving the journal high visibility among radiologists, nuclear medicine specialists, oncologists and oncological surgeons全部文章以知识共享许可开放获取出版，使期刊在放射科医师、核医学专家、肿瘤学家与肿瘤外科医师中具有很高可见度。

History

• Cancer Imaging was founded in 2000 as the official publication of the International Cancer Imaging Society, with Rodney Reznek as founding editor, and its first volume carried papers from the first ICIS conference《癌症成像》于 2000 年创刊，为国际癌症成像学会（ICIS）的官方出版物，创刊主编为（Rodney Reznek），首卷收录了首届（ICIS）会议论文。^[1]
• In its early years the journal was published in London by e-Med Ltd, as reflected in the DOI prefix 10.1102 of articles from that period创刊初期该刊由伦敦（e-Med Ltd）出版，这一时期文章的（DOI）前缀为 10.1102。
• Since 2014 the journal has been published by BioMed Central, now part of Springer Nature, and has been fully open access since then2014 年起该刊改由（BioMed Central）出版，现隶属（Springer Nature），并自此全面开放获取。
• The journal carries the print ISSN 1740-5025 and the electronic ISSN 1470-7330 and is now an online-only title该刊印刷刊号为 1740-5025、电子刊号为 1470-7330，现为纯在线出版。
• The 2025 Journal Impact Factor is 4.8, against 3.5 in 2024, 5.605 in 2022 and 3.909 in 20212025 年影响因子为 4.8，2024 年为 3.5，2022 年为 5.605，2021 年为 3.909。
• In the 2025 Journal Citation Reports the journal ranks Q1 in Radiology, Nuclear Medicine and Medical Imaging and Q2 in Oncology在 2025 年《期刊引证报告》中，该刊位列核医学与医学影像类 Q1、肿瘤学类 Q2。

Editors

• The Editor-in-Chief is Khaled Elsayes, MD, Professor at the University of Texas MD Anderson Cancer Center in the United States现任主编为美国得克萨斯大学安德森癌症中心（MD Anderson Cancer Center）教授（Khaled Elsayes）。
• Deputy editors are Katherine Krajewski of the Dana-Farber Cancer Institute, Elaine Lee of the University of Hong Kong, Olivier Lucidarme of the Pitie-Salpetriere University Hospital in Paris and Thorsten Persigehl of University Hospital Cologne副编辑包括美国丹娜法伯癌症研究院的（Katherine Krajewski）、香港大学的（Elaine Lee）、法国巴黎皮蒂耶萨尔佩特里耶医院大学的（Olivier Lucidarme）与德国科隆大学医院的（Thorsten Persigehl）。
• An international group of experts serves as section editors covering all the sub-specialty areas of oncological imaging一批国际专家担任学部编辑，覆盖肿瘤影像的各亚专业领域。
• The journal operates single-anonymous peer review, in which reviewers know the authors but their reports to the authors are anonymous该刊实行单盲评审，审稿人知晓作者身份，但提供给作者的评审报告匿名。
• The median time from submission to first decision is 8 days, and the journal recorded 1.3 million downloads in 2025投稿至首次决定的中位时间为 8 天，2025 年下载量达 130 万次。
• The Reznek Prize, named after founding editor Rodney Reznek, is awarded annually to the authors of the journal's most cited article, and ICIS members receive a 20% discount on the article publishing charge以创刊主编（Rodney Reznek）命名的（Reznek Prize）每年授予该刊被引次数最高文章的作者，（ICIS）会员投稿可享 20% 的论文出版费减免。